Nine new hem12 haploid mutants of baker's yeast (Saccharomyces cerevisiae), totally or partially deficient in uroporphyrinogen decarboxylase activity, were subjected to both genetic and biochemical analysis. The mutations sites studied are situated far apart within the HEM12 gene located on chromosome IV. Uroporphyrinogen decarboxylase activity in the cell-free extracts of the mutants was decreased by 50-100 %. This correlated well with the decrease of haem formation and the increased accumulation and excretion of porphyrins observed in vivo. The pattern of porphyrins (uroporphyrin and its decarboxylation products) accumulated in the cells of mutants partially deficient in uroporphyrinogen decarboxylase activity did not differ significantly, although differences in vitro were found in the relative activity of the mutant enzyme at the four decarboxylation steps. The excreted porphyrins comprised mainly dehydroisocoproporphyrin or pentacarboxyporphyrin. In heterozygous hem12-1/HEM12 diploid cells, a 50 % decrease in decarboxylase activity led to an increased accumulation of porphyrins as compared with the wild-type HEM12/HEM12 diploid, which points to the semi-dominant character of the hem12-1 mutation. The biochemical phenotypes of both the haploid and the heterozygous diploid resembles closely the situation encountered in porphyria cutanea tarda, the most common human form of porphyria.
INTRODUCTION
Uroporphyrinogen decarboxylase (uroporphyrinogen carboxylyase, EC 4.1.1.37) is the fifth enzyme of the haem-biosynthetic pathway and catalyses sequential decarboxylation of four acetate side chains of uroporphyrinogen III to yield coproporphyrinogen III, with formation of intermediates: hepta-, hexa-and pentacarboxyporphyrinogens [1] [2] [3] . Jackson et al. [1] proposed that the stepwise decarboxylation of uroporphyrinogen III to coproporphyrinogen III proceeds in a clockwise fashion, starting with the acetic acid group in the D-ring of uroporphyrinogen III. This is followed by successive decarboxylation of the side groups in rings A, B and C. The acetate chains of uroporphyrinogen I are also decarboxylated to form coproporphyrinogen I, which is no further metabolized. The decarboxylation of uroporphyrinogen I proceeds randomly. All intermediate porphyrinogens with less than eight carboxy groups can serve as substrates for decarboxylase [4, 5] . The enzyme has been purified from various sources [6] [7] [8] [9] , and its amino acid sequence was recently reported [10] . Despite many efforts to elucidate it, the mechanism of uroporphyrinogen decarboxylase action is still not clear [2, [4] [5] [6] [7] [8] [9] [11] [12] [13] [14] ; in particular, there is still controversy as to whether the sequential decarboxylations are catalysed by single active centre or separate active centres are involved.
The study of uroporphyrinogen decarboxylase is of particular interest, since an inherited or acquired deficiency of the enzyme activity is the cause of the most common human porphyria, porphyria cutanea tarda, characterized by increased excretion of uroporphyrin and some of its decarboxylation products. The molecular defects underlying these enzyme deficiencies have not yet been characterized, except in one case of homozygous porphyria cutanea tarda, where the nature of the mutation has been determined [15] .
Our previous results demonstrated that the functioning of uroporphyrinogen decarboxylase in baker's yeast (Saccharomyces cerevisiae) is very similar to that in mammalian cells, and we described a yeast mutant with biochemical characteristics mimicking those found in porphyria cutanea tarda [16] . We isolated new mutants affected in the gene coding for uroporphyrinogen decarboxylase, namely HEM12 [17] , which could serve as new tools for investigating the mode of action of the enzyme both in vitro and in vivo [17, 18] .
In the present paper a comparison of the various mutants defective in HEM12 locus was made in respect of porphyrin accumulation and haem production as a consequence of the differing extents of uroporphyrinogen decarboxylase deficiency.
EXPERIMENTAL Strains
The principal strains of baker's yeast (Saccharomyces cerevisiae) used in the present study are listed in Table 1. I To whom correspondence and reprint requests should be addressed.
Vol. 253 [17] heml2-5 ipal-l Sm40 a leul arg4 ctal-I heml2-6 [17] DSm65-2C a leu2 His-ura3 heml3-1 [17] General genetic methods Conventional procedures of yeast genetics, namely crossing, sporulation and tetrad analysis, were used to construct strains with desired markers and to determine linkage relationships. The frequency of intragenic recombinations were estimated in two-factor crosses between heml2 alleles by the meiotic method [19, 20] .
Growth conditions and preparation of cell-free extracts Cells were grown in a complete medium containing 1 % yeast extract, 1 % Bacto-Peptone, 0.1 % (w/v) Tween 80 (+ 20 mg of ergosterol/litre) and 2 % (w/v) glucose (YPG-medium) or 2 % ethanol (YPE-medium) as a carbon source. Cells were grown at 30°C with vigorous aeration and harvested at the end of the exponential phase of growth, washed with water and broken with glass beads [21] .
Enzyme assay
Uroporphyrinogen decarboxylase assay was performed with 2-5 mg of protein of the cell-free extracts as described in detail previously [3] . Uroporphyrinogen I or III (5-10 gM final concn.) was used as substrate. The assay was performed anaerobically in the dark. Samples were withdrawn at determined time intervals, and porphyrins (substrates and reaction products) were analysed and quantified by h.p.l.c. The specific activity of the enzyme was estimated as the sum of the hepta-, hexa-, penta-and tetra-carboxyporphyrins (nmol) formed/h per mg of protein.
Haem content Haem concentration in cells was determined spectrophotometrically as described previously [22] .
Content of intracellular and excreted porphyrins Concentrations of intracellular and excreted porphyrins were measured spectrophotometrically in 3 M-HCI extracts, and porphyrins were identified by the h.p.l.c. technique [3] .
RESULTS AND DISCUSSION Genetic data
Mutants, 11 in all, listed in Table 1 , defective in the HEM12 gene coding for uroporphyrinogen decarboxylase, were isolated. All of them accumulated large amounts of porphyrins and showed fluorescence under u.v. light. They were of two types: hem12-1, hem12-8, hem12-9, heml2-11 could not grow on a non-fermentable carbon source because of complete haem deficiency, whereas heml2-2, heml2-3, heml2-4, hem12-5, hem12-6 and heml2-10, capable of partial haem synthesis, were able to grow on a non-fermentable carbon source. The assignment of mutants for gene HEM12 was based on enzyme-activity assay [3, 22] and by means of the complementation test [17] . We established that the HEM12 locus was linked to the TRPI locus (centromerelinked marker of chromosome IV) with a map distance of 35 centrimorgans, and to HEMB3 locus (gene coding for coproporphyrinogen oxidase [23] ) with an average map distance of 10 centimorgans. The data of tetrad analysis indicating linkage for these loci are presented in Table 2 and Fig. 1 . It was found that the recombination frequencies differed depending on the heml2 allele used in the cross with heml3-1. Therefore we tested the frequencies ofintragenic recombination between different alleles of heml2 mutants. Since no method is available for positive selection of wild-type recombinants (negative selection permits one to distinguish between fluorescent and non-fluorescent colonies), the recombination was studied by means of tetrad analysis. Diploids (heml2-x/ heml2-y) were constructed, sporulated, and the tetrads were dissected and analysed for non-fluorescent wild-type recombinants. Only complete tetrads were analysed. The Tables 2   and 3 . Mutants hem12-4, hem12-9 and hem12-11 in crosses with other heml2 alleles sporulated and germinated very poorly, and no complete tetrads were obtained. The mutant heml2-5 was not further analysed, since the expression of the uroporhyrinogen decarboxylase deficiency appeared to be dependent on a second mutation (T. Zoladek, unpublished work). Abbreviation: cM, centimorgan.
recombination frequencies in each cross are summarized in Table 3 . They appear to be surprisingly high, but similar frequencies have been observed in yeast [24] . Although the samples of tetrads were too small for calculation of the genetic distances between the mutant sites, the values are, nevertheless, consistent and permit approximate location of the mutants within the HEM12 locus ( Fig. 1 ). Thus it can be unequivocally stated that the mutants studied are scattered throughout the HEM12 gene. Uroporphyrinogen decarboxylase activity in cell-free extracts of heml2 mutants
The accumulation of decarboxylation products of uroporphyrinogen I and III incubated anaerobically with extracts of wild-type and mutant cells was compared at a fixed substrate concentration (10 /M and 8 /M respectively) and 2-5 mg of protein. For the enzyme assay, the mutants partially defective in haem synthesis were grown on glucose or on ethanol. The extracts of cells grown on either carbon source showed the same pattern of accumulation of decarboxylation products, though the activity was higher in the cells grown on ethanol. In the present paper, only the data obtained with the latter cells are presented. The totally-haemdeficient mutants had to be grown on glucose.
The data presented in Table 4 show that the enzyme activity in extracts from mutant cells was significantly decreased and corresponded to 0-30 0% (for uroporphyrinogen III) and 0-60 Qo (for uroporphyrinogen I) of the values for the standard strain. The specific activity as a measure of the enzyme deficiency was expressed in a simplified manner as the sum (nmol) of hepta-, hexa-, penta-carboxy-and coproporphyrinogens formed during 1 h of the reaction. This, however, does not fully reflect the kinetics of successive decarboxylations. To illustrate the complexity of the reaction, the relative rates of accumulation of different decarboxylation products catalysed by parental and five mutant enzymes are presented graphically ( Fig. 2a and 2b) .
As expected, the completely-haem-deficient mutants, hem12-7 and hem12-8, like the previously described mutant hem12-1 [22] , contained no detectable activity of the enzyme. In the heml2-9 mutant the activity was barely detectable; unexpectedly, the specific activity of the enzyme in the heml2-11 mutant was of the same magnitude as that in mutants partially blocked in haem synthesis. However, only the products of the first and second decarboxylations were found. As shown in Fig. 3 , the formation of hepta-and hexa-carboxyporphyrinogen was linear over 1 h, and heptacarboxyporphyrinogen was the species mainly accumulated (85 0o).
As for the mutants partially defective in haem synthesis, from the graphs presented in Fig. 2(a) it appeared that the enzyme in the heml2-10 strain was almost inactive in the 'in vitro' assay, and it was rather surprising to find that haem was synthesized in the mutant cells (Table 4 , Fig. 4) . It seems that mutation in this case led to a defect in the first decarboxylation step and, in consequence, formation of further reaction products was dramatically diminished.
The alternative explanation is that the mutation led to an instability of the defective enzyme in vitro. Also, in the heml2-6 mutant, the diminished accumulation of the first decarboxylation product was accompanied by a marked decrease of the rates of subsequent reactions. In mutants heml2-3 and heml2-4 the accumulation of heptacarboxyporphyrinogen was similar to that in the parental strain, whereas the rates of accumulation of all other decarboxylation products were diminished; these differences were more pronounced in the heml2-4 than in the heml2-3 strain. It should be emphasized that, in all the mutants studied, formation of coproporphyrinogen was impaired to the greatest extent.
The decarboxylation of uroporphyrinogen III by the -wild-type enzyme was faster then that of its isomer I (Table 4) , which is in agreement with the data reported for rat liver uroporphyrinogen decarboxylase [4] . With uroporphyrinogen III as a substrate, coproporphyrinogen accumulated at the highest rate (Fig. 2a) , whereas with uroporphyrinogen I as a substrate the rate of coproporphyrinogen accumulation was significantly lower (Fig. 2b) . In mutants, independently of the substrate used, almost no coproporphyrinogen was formed. Therefore, the impairment of the fourth decarboxylation step in mutants has smaller effect on the total activity with uroporphyrinogen as a substrate. In all mutants except hem12-11 the formation of heptacarboxyporphyrinogen I was diminished. Similarly, as with uroporphyrinogen III, the activity of the enzyme was most affected in hem12-6 and hem12-10 cells.
The assay ofuroporphyrinogen I and III decarboxylase activity in vitro revealed differences in the rates of accumulation of particular decarboxylation products in hem12 mutants. However, only in strain heml2-11 did the mutation lead specifically to the blocking of the third decarboxylation step (Fig. 3) . This is the only mutant which seems to be affected in the specific catalytic site, suggesting the existence of more than one such site. The total lack of any of the decarboxylation steps with either substrate (uroporphyrinogen III and I) in the mutants hem12-1, hem12-7, hem12-8 and hem12-9 could be explained in five alternative ways: (1) absence of protein (nonsense or frameshift mutations); (2) instability of the enzyme; (3) inability to bind the substrate; (4) inactivation of catalytic site (assuming that there is only one); or (5) inactivation of the catalytic site responsible for the first decarboxylation step if there is more than one active centre.
In the other mutants with a residual activity of the enzyme the different mutations, though scattered within the gene, affected all the decarboxylation steps. The data do not favour the four-active-centre hypothesis; however, nor do they prove that there is only one such centre.
The reaction catalysed by uroporphyrinogen decarboxylase is very complex: a single enzyme catalyses four successive decarboxylation steps. The decarboxylated substrates, porphyrinogens, and porphyrins (the oxidized intermediates) act as inhibitors of the reaction [4, 5, 8, 9] . This complexity precludes unequivocal interpretation of the presented data.
The comparison of the kinetics of decarboxylation using hepta-, hexa-or penta-carboxyporphyrinogens from isomeric series III and I and identification of the isomer type of the intermediates would have allowed more definite conclusions to have been made. Effect in vivo of uroporphyrinogen decarboxylase deficiency in heml2 mutants As described previously [3] , partial uroporphyrinogen decarboxylase deficiency in the heml2-2 mutant led to the accumulation in cells of uroporphyrin and heptacarboxyporphyrin, accompanied by a low content of haem. It seemed worthwhile, therefore, to examine how the modification of uroporphyrinogen decarboxylation steps found in vitro for other heml2 mutants influenced functioning of the defective enzyme in vivo.
As shown in Table 4 and Fig. 4 , a large amount of porphyrin was accumulated in mutant cells, exceeding 10-40 times that found in wild-type cells. The amount of excreted porphyrins was 1-5 times higher than in the wild-type (Table 4 ). There was a distinct correlation between the level of uroporphyrinogen decarboxylase activity and haem and porphyrin production. The lower the enzyme activity, the less haem was formed and the greater was the accumulation of porphyrins. However, there was no overproduction of porphyrins: the production of tetrapyrroles expressed as the sum of with cell-free extracts obtained from wild-type parent (WIT) and heml2 mutants grown on ethanol medium The conditions of the assay were as described in [3] . A, 0 and LI, hepta-, hexa-and penta-carboxyporphyrins; V, coproporphyrin. The presence of heptacarboxyporphyrin at zero time is due to minor contamination of the substrate, uroporphyrin, with this porphyrin. The pattern of porphyrin accumulation was highly reproducible, so only the results corresponding to one experiment are shown. intracellular and excreted porphyrin intermediates, as well as cellular haem concentration, were almost the same in parental and mutant cells. This indicates that porphyrin accumulation in hem12 mutants results from uroporphyrinogen decarboxylase deficiency and not from impaired regulation of the haem-biosynthetic pathway.
An analysis of the nature of porphyrins accumulated revealed that, in hem12-7 and hem12-8 mutants, where haem synthesis is totally blocked, uroporphyrin was practically the only accumulated product, as in the heml2-1 strain (Fig. 5 ) [22] . In the heml2-11 mutant the pattern of intermediates accumulated resembled that of heml2-2 [3] . The appearance of penta-and tetracarboxyporphyrins in heml2-11 cells is surprising, since, in the assay in vitro, no detectable activity relating to the Vol. 253 last two decarboxylation steps was found. Probably heml2-11 is a 'leaky' mutation, and during 18 h of growth the intermediates, which are produced at a very low rate, can accumulate. Therefore it seems that the assay in vivo reflects more faithfully the functioning of the modified enzyme in the cell. In all mutants with residual activity of uroporphyrinogen decarboxylase, including heml2-11, uroporphyrin was the main accumulation product. It accounted for 40-70 % of the total porphyrins. The proportion of hepta-, hexa-and penta-carboxy intermediates did not differ significantly, although in heml2-11, as in hem12-2, heptacarboxyporphyrin predominated. There was a small amount of coproporphyrin or, as in hem12-10, none at all. The excreted porphyrins comprised mainly pentacarboxyporphyrin and dehydroisocoproporphyrin (up to 50 % of total porphyrins excreted; data not shown), whereas wild-type cells excreted mainly coproporphyrin (74 %).
From the results presented it appears that, irrespective of the extent of the enzyme deficiency and of the differences in the functioning of the mutated enzyme in vitro, the proportion of accumulated and excreted porphyrins remained similar. The same has been found in mammals; a more or less severe decrease of uroporphyrinogen decarboxylase activity caused by mutation or treatment with chemicals resulted in a similar pattern of porphyrins excreted in the urine or faeces, or accumulated in liver [25, 26] , which suggest the same mode of enzyme action in yeast and mammals.
It is not surprising that, in porphyria cutanea tarda, the porphyrin accumulated in liver and excreted in urine consists not only of uroporphyrin [5] , since the mutants accumulating only uroporphyrin were characterized by a total lack of uroporphyrinogen decarboxylase activity, leading to a lack of haem. Such a lesion would be lethal for any obligatory aerobe, whereas S. cerevisiae can survive owing to its ability to ferment.
Expression of uroporphyrinogen decarboxylase deficiency in a heterozygous diploid
We compared the profiles of porphyrins accumulated in the cells of mutants deficient in uroporphyrinogen decarboxylase activity with those found in human porphyria cutanea tarda. Such a comparison is applicable only to the heritable form of that porphyria. It is generally maintained that one form of the disease is inherited as an autosomal dominant trait [5, [25] [26] [27] [28] . To study the possible interaction between the wild-type and mutant hem12 alleles in yeast heterozygotes, we constructed a homozygous wild-type diploid, HEM12/ HEM12 (FL100/SP4), and a heterozygous one, hem12-1/ HEM12 (G121/SP4). In heml2-1 mutant cells, owing to the complete block of uroporphyrinogen decarboxylase activity, only uroporphyrin was accumulated [22] . According to the criteria applied to screen the hem12 mutants, i.e. visible porphyrin accumulation in low-temperature spectra of whole cells and fluorescence under u.v. light [17, 22] , it was assumed that the heml2-1 mutation was recessive. The detailed analysis of porphyrins accumulated in diploid cells revealed the difference between the wild-type and heml2-1/HEM12 strains, indicating that heml2-1 mutation was not entirely recessive. The results presented in Table 5 and Fig. 6 show that the level of intracellular porphyrins in the heterozygous diploid was about 3 times higher than in the wild-type homozygote. The elevated level of porphyrins was due mainly to accumulation ofuroporphyrin, but the amount of hepta-, hexa-and penta-carboxy intremediates was also increased, similarly to single hem12 mutants partially deficient in uroporphyrinogen decarboxylase activity. The accumulation of porphyrins in the heterozygote was correlated with a 50 % decrease in the activity of uroporphyrinogen decarboxylase (results not shown). However, no decrease in haem content was observed.
From the present results it appears that the increased concentration of uroporphyrin and its decarboxylation products in the heterozygote tested was insufficient to produce visible fluorescence of cells or visible porphyrin peaks in the spectra of whole cells. Our preliminary results suggest some resemblance of these heterozygotes to familial cases of porphyria cutanea tarda [5, [26] [27] [28] [29] [30] , where, most often, the diminished uroporphyrinogen decarboxylase activity was not clinically expressed. However, it may be assumed that this disorder of porphyrin metabolism is due to a genetic predisposition and that its expression can be induced by toxic factors or additional mutations. The preliminary data presented here point to the usefulness of studying the diploids heterozygous for hem12 mutant alleles.
The analysis of porphyrins in number of diploids with different combinations ofheml2 alleles and the possibility of induction of new mutations changing the expression of mutant alleles in diploids provide us with a relatively simple system for studying the genetic defects underlying the differences in the expression of uroporphyrinogen decarboxylase deficiency. Table 5 . Accumulation of porphyrins by diploid strains: homozygotic HEM12/HEM12 and heterozygotic heml2/HEM12 Assay conditions were as described in Table 4 
